Tradestie Institutional Equity Comparison Engine

LLY vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Momentum & Technical, Options & Structure while LLY counters with relative strength in Growth & Margin. Fundamentally, LLY trades at 26.5x Forward P/E with 51.2% operating margin (+38.6% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, LLY sits in CONSOLIDATION (23rd %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
LLY 26.5x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner LLY
Op Margin 51.2% vs 2.5% ยท YoY +38.6% vs +54.9%
Momentum & Technical Winner AVDL
1Y +28.4% vs +138.1% ยท 52W Pos 80% vs 89%
Options & Structure Winner AVDL
CONSOLIDATION (23rd %ile IV) vs UNCLASSIFIED (<1st %ile IV)
LLY NYSE
Eli Lilly & Co.
Pharmaceutical Preparations
$1,347.11
-0.3% 1D
Market Cap $1.20T
1M Return +3.09%
1Y Return +28.35%
Forward P/E 26.5x
Unified AI Score
41.4 / 100 SELL
Tech 39.0 Fund 44.0 Flow 67.0 Mom 21.1
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LLY +28.35% AVDL +138.06% Spread: +3.04 pp (LLY Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LLY TTM Op. Margin: 51.2% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LLY vs AVDL. Trailing 12-month operating profitability (LLY 51.2% vs AVDL 2.5%) and valuation multiples (LLY 26.5x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LLY (5) vs AVDL (5)
Institutional Metric LLY AVDL Criterion Row Winner
Market Capitalization Scale $1.20T $2.1B Larger Scale LLY
Trailing P/E Ratio Valuation 44.9x 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation 26.5x 28.8x Lower Multiple LLY
Revenue Growth (YoY) Growth +38.6% +54.9% Higher Growth AVDL
Operating Margin (TTM) Profitability 51.2% 2.5% Higher Margin LLY
Net Profit Margin Profitability 31.9% -0.1% Higher Margin LLY
Return on Equity (ROE) Capital Efficiency 86.0% -0.3% Higher ROE LLY
52-Week Range Position Momentum 80% ($851โ€“$1,475) 89% ($6โ€“$24) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 0.32ฮฒ ยท 36% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 41.4 / 100 (SELL) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LLY vs AVDL Buy Guide
LLY CONSOLIDATION
97d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 23rd %ile
IV Regime Compressed (<25th %ile)
Live LLY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LLY nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.